Cargando…
Structural insights into binding specificity, efficacy and bias of a β(2)AR partial agonist
Salmeterol is a partial agonist for the β(2) adrenergic receptor (β(2)AR), and the first long-acting β(2)AR agonist (LABA) to be widely used clinically for the treatment of asthma and chronic obstructive pulmonary disease. Salmeterol has been controversial both for its safety and mechanism of action...
Autores principales: | Masureel, Matthieu, Zou, Yaozhong, Picard, Louis-Philippe, van der Westhuizen, Emma, Mahoney, Jacob P., Rodrigues, João P.G.L.M., Mildorf, Thomas J., Dror, Ron O., Shaw, David E., Bouvier, Michel, Pardon, Els, Steyaert, Jan, Sunahara, Roger K., Weis, William I., Zhang, Cheng, Kobilka, Brian K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197491/ https://www.ncbi.nlm.nih.gov/pubmed/30327561 http://dx.doi.org/10.1038/s41589-018-0145-x |
Ejemplares similares
-
Allosteric coupling from G protein to the agonist binding pocket in GPCRs
por: DeVree, Brian T., et al.
Publicado: (2016) -
Crystal Structure of the β(2)Adrenergic Receptor-Gs protein complex
por: Rasmussen, Søren G.F., et al.
Publicado: (2011) -
Constrained catecholamines gain β(2)AR selectivity through allosteric effects on pocket dynamics
por: Xu, Xinyu, et al.
Publicado: (2023) -
N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor
por: Zou, Yaozhong, et al.
Publicado: (2012) -
Author Correction: Constrained catecholamines gain β(2)AR selectivity through allosteric effects on pocket dynamics
por: Xu, Xinyu, et al.
Publicado: (2023)